These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7520786)

  • 1. Possible correlation of b3-a2-type bcr-abl messenger RNA defined by semiquantitative RT-PCR to platelet and megakaryocyte counts in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Futaki M; Dan K; Nomura T
    Intern Med; 1994 Apr; 33(4):189-92. PubMed ID: 7520786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the type of bcr-abl hybrid messenger RNA and thrombopoiesis in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Nomura T
    Leuk Lymphoma; 1993 May; 10(1-2):9-15. PubMed ID: 8374529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Inoue T; Tojo A; Futaki M; Miyake K; Yamada T; Tanabe Y; Ohki I; Dan K; Ozawa K
    Blood; 1991 Dec; 78(12):3125-7. PubMed ID: 1742479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia.
    Inoue T; Tojo A; Tsuchimoto D; Okamoto S; Ogura H; Tani K; Ozawa K; Shibuya M; Asano S
    Leukemia; 1992 Sep; 6(9):948-51. PubMed ID: 1518306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.
    Nakata Y
    Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia.
    Wells SJ; Phillips CN; Winton EF; Farhi DC
    Am J Clin Pathol; 1996 Jun; 105(6):756-60. PubMed ID: 8659451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene.
    Mills KI; Sproul AM; Leibowitz D; Burnett AK
    Leukemia; 1991 Nov; 5(11):937-41. PubMed ID: 1961034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia.
    Perego RA; Costantini M; Cornacchini G; Gargantini L; Bianchi C; Pungolino E; Rovida E; Morra E
    Eur J Cancer; 2000 Jul; 36(11):1395-401. PubMed ID: 10899653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers.
    Furukawa Y; Ju SL; Cho HL; Tatsumi N
    Osaka City Med J; 1993 Jun; 39(1):35-45. PubMed ID: 7694218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular studies of chronic myelogenous leukemia using the polymerase chain reaction.
    Nakamura K; Miyashita T; Ozaki M; Iwaya M; Nakazawa S; Okamura J; Kamada N; Tanaka K; Kobayashi N; Mizutani S
    Cancer; 1991 Dec; 68(11):2426-30. PubMed ID: 1933779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis.
    Martinelli G; Testoni N; Montefusco V; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazzi F; de Vivo A; Pane F; Rosti G; Tura S
    Haematologica; 1998 Jul; 83(7):593-601. PubMed ID: 9718863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection by polymerase chain reaction of BCR/ABL transcripts in myeloproliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukaemia patients after bone marrow transplantation.
    Bianchi C; Cairoli R; Marenco P; Muti G; Del Monte U; Perego RA
    Eur J Cancer; 1995; 31A(2):197-201. PubMed ID: 7718325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Philadelphia negative chronic myelogenous leukemia with the chimeric BCR/ABL gene on chromosome 9 and a b3-a2 splice junction.
    Macera MJ; Smith LJ; Frankel E; Szabo P; Verma RS
    Cancer Genet Cytogenet; 1998 Mar; 101(2):143-7. PubMed ID: 9494617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of bcr/c-abl mRNA in chronic myelogenous leukemia by polymerase chain reaction to identify chromosome translocation.
    Lin CP; Chen PM; Yen JS; Wang RL; Lee LS; Chen PH; Chang JG
    J Formos Med Assoc; 1992 Mar; 91(3):247-51. PubMed ID: 1354683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2.
    Iwata S; Mizutani S; Nakazawa S; Yata J
    Leukemia; 1994 Oct; 8(10):1696-702. PubMed ID: 7934165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
    Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
    Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation by bcr-abl mRNA and DNA fingerprinting.
    Okamoto R; Harano H; Matsuzaki M; Motomura S; Maruta A; Kodama F; Mohri H; Okubo T
    Am J Clin Pathol; 1995 Nov; 104(5):510-6. PubMed ID: 7572810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
    Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.